Data AnalysisVerified
Reviewed and published by trentmaziarz, July 9, 2026. Discovered and drafted by our automated research pipeline.
Boston Scientific deployed BeatLogic, a deep-learning algorithm that automatically analyzes ECG data from cardiac monitoring devices to detect and classify 34 distinct arrhythmias. The system processes over 3 billion heartbeats daily across patients in the United States and sends critical alerts to physicians.
Details
BeatLogic is the AI algorithm suite built into Boston Scientific's Cardiac Diagnostics cloud-based ECG analysis platform, and is also integrated across the BodyGuardian family of remote cardiac monitors. The algorithm was developed using 125,000+ patient records and 7.5+ million ECG records, applying multiple specialized deep-learning models to raw ECG input to produce classified arrhythmia reports and urgent notifications. A clinical study found that AI-guided rhythm adjudication using BeatLogic was near-identical in accuracy to a consensus of three expert electrophysiologists.
Products affected
BeatLogicBodyGuardian Remote Cardiac MonitorsBoston Scientific Cardiac Diagnostics Platform
Sources & Evidence
Company Disclosure
Cite this record
Trace Foundation. (2026). Boston Scientific: Boston Scientific deployed BeatLogic, a deep-learning algorithm that automatically analyzes ECG data from cardiac monitoring devices to detect and classify 34 distinct arrhythmias. The system processes over 3 billion heartbeats daily across patients in the United States and sends critical alerts to physicians (data as of 2026-07-09) [Data set record]. AI Trace. https://www.aitrace.org/r/practice/033bf9c5-5d64-488d-9922-02dc9c5705b0. Accessed October 7, 2026.
- Stable link
- https://www.aitrace.org/r/practice/033bf9c5-5d64-488d-9922-02dc9c5705b0
- Data as of
- July 9, 2026
- Last verified
- August 4, 2026
Other practices by Boston Scientific
RecommendationBoston Scientific integrated Coveo's AI-search platform into its B2B e-commerce site to deliver personalized search results, relevance tuning, and behavior-based product recommendations for healthcare facility buyers and sales representatives. The integration has been underway for approximately four years.Data AnalysisBoston Scientific deployed the AVVIGO+ Multi-Modality Guidance System, which includes an AI software feature called Automated Lesion Assessment that automatically identifies and measures coronary artery blockages during heart procedures. The system received FDA clearance in September 2023.Data AnalysisBoston Scientific deployed the LUX-Dx II+ Insertable Cardiac Monitor, which uses an enhanced dual-stage algorithm to automatically detect and verify potential arrhythmias in patients before sending alerts to clinicians. The device is implanted under the skin for long-term continuous heart monitoring.
Have evidence about Boston Scientific's AI practices? Submit a report.
Report a Sighting →